A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
NCT ID: NCT06212999
Last Updated: 2026-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE3
617 participants
INTERVENTIONAL
2024-01-30
2026-12-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
NCT05620823
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
NCT05620836
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
NCT06799000
Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT06118099
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
NCT05889182
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort A
Povorcitinib at the protocol-defined dose strength based on cohort assignment.
Povorcitinib
Oral; Tablet
Cohort B
Povorcitinib at the protocol-defined dose strength based on cohort assignment.
Povorcitinib
Oral; Tablet
Cohort C
Povorcitinib at the protocol-defined dose strength based on cohort assignment.
Povorcitinib
Oral; Tablet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Povorcitinib
Oral; Tablet
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Agreement to use contraception.
* Willing and able to comply with the study protocol and procedures.
Exclusion Criteria
* Women who are pregnant (or who are considering pregnancy) or breastfeeding.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Incyte Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Incyte Medical Monitor
Role: STUDY_DIRECTOR
Incyte Corporation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Investigative Site BG201
Stara Zagora, , Bulgaria
Investigative Site CA202
Calgary, Alberta, Canada
Investigative Site CA204
Edmonton, Alberta, Canada
Investigative Site CA200
Surrey, British Columbia, Canada
Investigative Site CA301
Winnipeg, Manitoba, Canada
Investigative Site CA205
Fredericton, New Brunswick, Canada
Investigative Site CA304
Barrie, Ontario, Canada
Investigative Site CA308
Hamilton, Ontario, Canada
Investigative Site CA303
London, Ontario, Canada
Investigative Site CA207
Mississauga, Ontario, Canada
Investigative Site CA302
Peterborough, Ontario, Canada
Investigative Site CA208
Richmond Hill, Ontario, Canada
Investigative Site CA307
Montreal, Quebec, Canada
Investigative Site CA206
Saint-Jérôme, Quebec, Canada
Investigative Site CA203
St. John's, , Canada
Investigative Site CZ301
Ostrava - Poruba, , Czechia
Investigative Site CZ300
Prague, , Czechia
Investigative Site DK200
Århus N, , Denmark
Investigative Site DK201
Roskilde, , Denmark
Investigative Site FR305
Bordeaux, , France
Investigative Site FR303
Brest, , France
Investigative Site FR205
Dijon, , France
Investigative Site FR307
Le Mans, , France
Investigative Site FR204
Lyon, , France
Investigative Site FR304
Marseille, , France
Investigative Site FR302
Nantes, , France
Investigative Site FR203
Nice, , France
Investigative Site FR300
Paris, , France
Investigative Site FR206
Reims, , France
Investigative Site FR202
Rouen, , France
Investigative Site FR301
Saint-Priest-en-Jarez, , France
Investigative Site FR306
Toulouse, , France
Investigative Site DE202
Berlin, , Germany
Investigative Site DE203
Bochum, , Germany
Investigative Site DE305
Darmstadt, , Germany
Investigative Site DE201
Dessau, , Germany
Investigative Site DE302
Dresden, , Germany
Investigative Site DE306
Düsseldorf, , Germany
Investigative Site DE207
Erlangen, , Germany
Investigative Site DE301
Frankfurt, , Germany
Investigative Site DE208
Göttingen, , Germany
Investigative Site DE303
Hamburg, , Germany
Investigative Site DE300
Hanover, , Germany
Investigative Site DE205
Heidelberg, , Germany
Investigative Site DE200
Kiel, , Germany
Investigative Site DE307
Memmingen, , Germany
Investigative Site DE206
Merzig, , Germany
Investigative Site GR300
Athens, , Greece
Investigative Site GR303
Athens, , Greece
Investigative Site GR302
Thessaloniki, , Greece
Investigative Site IT200
Ancona, , Italy
Investigative Site IT207
Catania, , Italy
Investigative Site IT202
Milan, , Italy
Investigative Site IT206
Pisa, , Italy
Investigative Site IT205
Roma, , Italy
Investigative Site IT201
Rozzano, , Italy
Investigative Site JP301
Ginowan-shi, , Japan
Investigative Site JP304
Itabashi-ku, , Japan
Investigative Site JP305
Kurume-shi, , Japan
Investigative Site JP300
Kyoto, , Japan
Investigative Site JP303
Niigata, , Japan
Investigative Site JP308
Sapporo, , Japan
Investigative Site JP302
Sendai, , Japan
Investigative Site JP309
Shinjuku-ku, , Japan
Investigative Site NL302
Breda, , Netherlands
Investigative Site NL303
Groningen, , Netherlands
Investigative Site NL301
Rotterdam, , Netherlands
Investigative Site PL203
Lublin, , Poland
Investigative Site PL304
Ostrowiec Świętokrzyski, , Poland
Investigative Site PL200
Rzeszów, , Poland
Investigative Site PL201
Warsaw, , Poland
Investigative Site PL202
Warsaw, , Poland
Investigative Site PL301
Wroclaw, , Poland
Investigative Site PL302
Wroclaw, , Poland
Investigative Site ES203
Alicante, , Spain
Investigative Site ES302
Badalona, , Spain
Investigative Site ES303
Barcelona, , Spain
Investigative Site ES301
Granada, , Spain
Investigative Site ES202
Las Palmas de Gran Canaria, , Spain
Investigative Site ES201
Madrid, , Spain
Investigative Site ES205
Madrid, , Spain
Investigative Site ES305
Madrid, , Spain
Investigative Site ES200
Manises, , Spain
Investigative Site ES300
Pontevedra, , Spain
Investigative Site ES304
Santiago de Compostela, , Spain
Investigative Site GB202
Birmingham, , United Kingdom
Investigative Site GB200
Dudley, , United Kingdom
Investigative Site GB203
Salford, , United Kingdom
Investigative Site US303
Phoenix, Arizona, United States
Investigative Site US240
Scottsdale, Arizona, United States
Investigative Site US307
Fort Smith, Arkansas, United States
Investigative Site US214
Rogers, Arkansas, United States
Investigative Site US315
Laguna Niguel, California, United States
Investigative Site US223
Los Angeles, California, United States
Investigative Site US222
Oakland, California, United States
Investigative Site US226
San Diego, California, United States
Investigative Site US309
Clearwater, Florida, United States
Investigative Site US317
Hialeah, Florida, United States
Investigative Site US306
Hollywood, Florida, United States
Investigative Site US320
Hollywood, Florida, United States
Investigative Site US316
Maitland, Florida, United States
Investigative Site US227
Margate, Florida, United States
Investigative Site US204
Miami, Florida, United States
Investigative Site US236
Miami, Florida, United States
Investigative Site US321
North Miami Beach, Florida, United States
Investigative Site US200
Ocala, Florida, United States
Investigative Site US228
Tampa, Florida, United States
Investigative Site US201
Tampa, Florida, United States
Investigative Site US311
Marietta, Georgia, United States
Investigative Site US220
West Dundee, Illinois, United States
Investigative Site US206
Indianapolis, Indiana, United States
Investigative Site US337
Indianapolis, Indiana, United States
Investigative Site US341
Bowling Green, Kentucky, United States
Investigative Site US209
Louisville, Kentucky, United States
Investigative Site US305
Baton Rouge, Louisiana, United States
Investigative Site US207
Metairie, Louisiana, United States
Investigative Site US229
New Orleans, Louisiana, United States
Investigative Site US224
Baltimore, Maryland, United States
Investigative Site US325
Marriottsville, Maryland, United States
Investigative Site US225
Boston, Massachusetts, United States
Investigative Site US304
Boston, Massachusetts, United States
Investigative Site US310
Brighton, Massachusetts, United States
Investigative Site US221
Quincy, Massachusetts, United States
Investigative Site US213
Fort Gratiot, Michigan, United States
Investigative Site US217
Waterford, Michigan, United States
Investigative Site US212
Minneapolis, Minnesota, United States
Investigative Site US302
St Louis, Missouri, United States
Investigative Site US318
Portsmouth, New Hampshire, United States
Investigative Site US230
East Windsor, New Jersey, United States
Investigative Site US324
Kew Gardens, New York, United States
Investigative Site US202
New York, New York, United States
Investigative Site US210
Rochester, New York, United States
Investigative Site US205
Chapel Hill, North Carolina, United States
Investigative Site US215
Bexley, Ohio, United States
Investigative Site US339
Bexley, Ohio, United States
Investigative Site US330
Boardman, Ohio, United States
Investigative Site US314
Cincinnati, Ohio, United States
Investigative Site US312
Cleveland, Ohio, United States
Investigative Site US203
Gahanna, Ohio, United States
Investigative Site US301
Portland, Oregon, United States
Investigative Site US232
Murfreesboro, Tennessee, United States
Investigative Site US235
Arlington, Texas, United States
Investigative Site US218
Bellaire, Texas, United States
Investigative Site US340
Bellaire, Texas, United States
Investigative Site US238
Pflugerville, Texas, United States
Investigative Site US300
Plano, Texas, United States
Investigative Site US234
San Antonio, Texas, United States
Investigative Site US313
Norfolk, Virginia, United States
Investigative Site US308
Spokane, Washington, United States
Investigative Site AU203
Charlestown, New South Wales, Australia
Investigative Site AU205
Kogarah, New South Wales, Australia
Investigative Site AU200
Liverpool, New South Wales, Australia
Investigative Site AU206
Woolloongabba, Queensland, Australia
Investigative Site AU207
Woolloongabba, Queensland, Australia
Investigative Site AU201
Carlton, Victoria, Australia
Investigative Site AU204
Melbourne, Victoria, Australia
Investigative Site AT306
Inssbruck, , Austria
Investigative Site AT305
Vienna, , Austria
Investigative Site BE300
Brussels, , Belgium
Investigative Site BE301
Ghent, , Belgium
Investigative Site BE302
Liège, , Belgium
Investigative Site BG203
Sofia, , Bulgaria
Investigative Site BG202
Sofia, , Bulgaria
Investigative Site BG200
Sofia, , Bulgaria
Investigative Site BG204
Sofia, , Bulgaria
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa (STOP-HS LTE)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-507204-31-00
Identifier Type: REGISTRY
Identifier Source: secondary_id
INCB 54707-312
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.